相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa
D. A. Hughes et al.
HEART (2008)
A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium
Frank Weidemann et al.
EUROPEAN HEART JOURNAL (2007)
Agalsidase-beta therapy for advanced Fabry disease - A randomized trial
Maryam Banikazemi et al.
ANNALS OF INTERNAL MEDICINE (2007)
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
Meinrad Beer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
Christine M. Eng et al.
GENETICS IN MEDICINE (2006)
The variation of morphological and functional cardiac manifestation in Fabry disease:: potential implications for the time course of the disease
F Weidemann et al.
EUROPEAN HEART JOURNAL (2005)
Fabry disease: overall effects of agalsidase alfa treatment
M Beck et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease - A prospective strain rate imaging study
F Weidemann et al.
CIRCULATION (2003)
Early detection of Fabry cardiomyopathy by tissue Doppler imaging
M Pieroni et al.
CIRCULATION (2003)
Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy
RJ Desnick et al.
ANNALS OF INTERNAL MEDICINE (2003)
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease - Evidence for a disease specific abnormality of the myocardial interstitium
JCC Moon et al.
EUROPEAN HEART JOURNAL (2003)
Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate
F Weidemann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
